Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory W Carter

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2024
Genetic diversity promotes resilience in a mouse model of Alzheimer's diseaseNeelakshi Soni, Lindsay A Hohsfield, Kristine M Tran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutationsGregg E Homanics, Jung Eun Park, Lauren Bailey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 12, 2024
New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshopMaria A Telpoukhovskaia, Thomas J Murdy, Olivia J Marola, et al.
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
PAK1 inhibitor NVS-PAK1-1 preserves dendritic spines in amyloid/tau exposed neurons and 5xFAD miceTao Yang, Hasi Huhe, Sean-Paul Williams, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2024
Genetic diversity promotes resilience in a mouse model of Alzheimer's diseaseNeelakshi Soni, Lindsay A Hohsfield, Kristine M Tran, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutationsGregg E Homanics, Jung Eun Park, Lauren Bailey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 12, 2024
New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshopMaria A Telpoukhovskaia, Thomas J Murdy, Olivia J Marola, et al.
Frontiers in Aging Neuroscience|February 24, 2022
Corrigendum: Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2<sup>*</sup>R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Frontiers in Aging Neuroscience|October 28, 2021
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47HKevin P Kotredes, Adrian Oblak, Ravi S Pandey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 12, 2024
Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Characterizing Molecular and Synaptic Signatures in mouse models of Late-Onset Alzheimer's Disease Independent of Amyloid and Tau PathologyKevin P Kotredes, Ravi S Pandey, Scott Persohn, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
PAK1 inhibitor NVS-PAK1-1 preserves dendritic spines in amyloid/tau exposed neurons and 5xFAD miceTao Yang, Hasi Huhe, Sean-Paul Williams, et al.
Pageof 13